Abstract
The number of survivors having undergone high-dose therapy (HDT) followed by auto-SCT continues to increase, although some of the long-term sequelae remain incompletely understood. The immunological status and quality of life of 37 HDT/auto-SCT survivors with lymphoma in continuous remission of ≥3 years were assessed alongside 14 age-matched controls. At a median follow-up of 10.5 years (range 2.2-20.2) following HDT/auto-SCT, the proportion of CD4(+) cells remained significantly reduced in patients compared with controls (median 43.4% vs 62.5%, respectively; P = < 0.001), predominantly a result of sustained reduction in the naive CD4(+) component (P < 0.001). Naive CD8(+) lymphocytes (P = 0.014) and transitional B cells (P = 0.008) were also significantly reduced, but differences in other lymphocyte subsets were not observed. Uptake of revaccination following HDT/auto-SCT was sporadic; between 11% and 33% of patients had serological titres outside the protective ranges for five of six routinely used vaccines. In the main, patients were found to have a good quality of life, although their EORTC QLQ-C30 questionnaire scores were significantly lower for the physical and social functioning domains compared with controls. Ten years...Continue Reading
References
Dec 7, 1995·The New England Journal of Medicine·T PhilipJ L Harousseau
Apr 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K PauksenB Simonsson
Apr 24, 1993·Lancet·D C LinchG V Hudson
Jul 1, 1993·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·V HammarströmP Ljungman
Mar 3, 1993·Journal of the National Cancer Institute·N K AaronsonJ C de Haes
Jul 25, 1998·Bone Marrow Transplantation·V HammarströmP Ljungman
Oct 12, 1999·Bone Marrow Transplantation·T NordøyA Husebekk
Jun 24, 2000·Lancet·D C DouekR A Koup
Aug 31, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A RavaudUNKNOWN EORTC-ECSG
May 25, 2002·Cytotherapy·UNKNOWN CDC, Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation
Jun 21, 2002·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·G KemmlerB Sperner-Unterweger
Jun 28, 2002·Lancet·Norbert SchmitzUNKNOWN Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Aug 23, 2003·Blood·Jean-François PoulinRémi Cheynier
Oct 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry C SchoutenGunnar Kvalheim
May 20, 2004·JAMA : the Journal of the American Medical Association·Karen L SyrjalaPaul J Martin
Mar 8, 2005·Bone Marrow Transplantation·P LjungmanUNKNOWN Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Jan 31, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J Douglas RizzoGérard Socié
Jun 25, 2008·The Journal of Experimental Medicine·Claude SportèsCrystal L Mackall